Discover Log In Sign Up
VTR
Ventas, Inc.
Business Overview
Summary
Earnings Call Analysis
Valuation
Profitability
Financial Health
+13%
+1.2% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US
Exchange NYSE
Industry REIT - Healthcare Facilities
Sector Real Estate
Market Cap $25.15B
CEO Ms. Debra A. Cafaro

Ventas, Inc. is a company that invests in and manages buildings used for healthcare, like hospitals and senior living facilities. They work with doctors, health organizations, and property developers to create safe and comfortable spaces for people to receive care. By owning many of these properties, Ventas helps ensure that healthcare providers can focus on helping their patients while also making a profit for their investors.

Core Products

πŸ₯
Healthcare Facilities Leased properties for care
πŸ”¬
Life Science & Research Laboratories and research
🀝
Development Partnerships Collaborative projects
πŸ‘΅
Senior Living Communities Housing for seniors

Business Type

B2B Business to Business

Competitive Advantages

πŸ‘΅
Demographic Tailwinds An aging population drives demand for healthcare facilities, providing a consistent growth opportunity.
🏒
Diversified Portfolio A broad range of properties across various healthcare sectors reduces risk and enhances stability.
πŸ’³
Robust Financial Position A strong balance sheet and access to capital allow for strategic investments and resilience during market cycles.
πŸ‘”
Experienced Management Team A skilled team with industry knowledge ensures effective strategy execution and operational efficiency.
🀝
Strong Industry Partnerships Collaborations with leading healthcare providers and institutions ensure access to quality tenants and innovation.

Key Business Risks

πŸ“‰
Market Volatility Fluctuations in the real estate market can affect property values and rental income.
πŸ”§
Operational Risks Challenges in managing a diverse portfolio of properties can lead to inefficiencies and increased costs.
πŸ‘΅
Demographic Shifts Changes in population demographics may alter demand for healthcare facilities and services.
βš–οΈ
Regulatory Changes Changes in healthcare regulations and policies may impact operational costs and revenue models.
🀝
Partnership Dependencies Reliance on key partners for operational success poses risks if partnerships falter or change.

Meeting Expectations

0 /0

Higher values indicate better execution and credibility

Recent Results

Takeaways

Ventas, Inc. demonstrates strong market positioning and a robust business model within the healthcare REIT sector, benefiting from demographic trends and a diversified portfolio. Its effective management and solid financial health bolster its attractiveness, although it faces inherent risks from market fluctuations and regulatory changes.

Historical data shows an impressive CAGR compared with the USA stock market average, reflecting a strong market position.

Yearly Return 10Y annualized return is positive but below market average at 1.2% per year
Earnings Expectations VTR has met or exceeded earnings expectations in all recent quarters (0/0)
Positive Healthy Gross Profit Margin
Positive Decent Operating Profit Margin
Positive Adequate Current and Quick Ratios
Positive Free Cash Flow Per Share
Positive πŸ† Strong Financial Performance
Positive πŸ“ˆ Competitive Positioning in Senior Housing
Positive πŸ” Data-Driven Investment Strategy
Positive πŸš€ Favorable Demographics for Growth
Positive πŸ—οΈ Strategic Expansion Plans
Positive πŸ’‘ Investment Pipeline
Negative Extremely High P/E Ratio
Negative High Price to Sales Ratio
Negative Low Net Profit Margin
Negative Weak Return on Equity
Negative High Debt Levels
Negative Low Interest Coverage Ratio

Overall, Ventas demonstrates strong business quality with robust financial performance, competitive positioning in senior housing, and a data-driven investment strategy. The future prospects are promising, fueled by favorable demographics and strategic expansion plans, indicating a positive growth trajectory.

Analysis Date: February 13, 2025
Last Updated: March 12, 2025

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Graham Value Metrics

Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.

Intrinsic Value

Estimated fair value based on Graham's formula

$0.72

Current Market Price: $68.03

IV/P Ratio: 0.01x (>1.0 indicates undervalued)

Margin of Safety

Gap between intrinsic value and market price

-9333.0%

Graham recommended a minimum of 20-30% margin of safety

Higher values indicate a greater potential discount to fair value

Graham Criteria Checklist

Benjamin Graham's value investing checklist for VTR

No Positive earnings (5+ years)
Yes Dividend history (5+ years)
No P/E ratio ≀ 20 (1135.46)
No P/B ratio ≀ 1.5 (2.56)
No Current ratio β‰₯ 2.0 (1.04x)
No Long-term debt < Net current assets (293.72x)
No Margin of safety (-9333.0%)
No VTR does not meet all Graham criteria

ROE: 0.8207106540359433

ROA: None

Gross Profit Margin: 30.50188596635519

Net Profit Margin: 0.49384273717138755

Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.

Healthy Gross Profit Margin

30.50%
Gross Profit Margin

The gross profit margin of 30.5% indicates a strong ability to retain a significant portion of revenue as profit, which is a positive indicator of operational efficiency.

Decent Operating Profit Margin

10.58%
Operating Profit Margin

An operating profit margin of 10.58% shows that the company is able to convert a reasonable portion of sales into operating profit, indicating effective cost management.

Low Net Profit Margin

0.49%
Net Profit Margin

The net profit margin of only 0.49% indicates that the company is not translating its revenue into profit effectively, which raises concerns about overall profitability.

Weak Return on Equity

0.25%
Return on Equity

A return on equity of 0.25% suggests that the company is not generating significant returns for shareholders, which could be a red flag for investors.

About Profitability Metrics

Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.

Return on Equity (ROE)

Measures how efficiently a company uses its equity to generate profits

0.82%

10% 15%

Higher values indicate better returns for shareholders

TTM (as of 2025-04-22)

Gross Profit Margin

Percentage of revenue retained after accounting for cost of goods sold

30.50%

20% 40%

Higher values indicate better efficiency in production

TTM (as of 2025-04-22)

Net Profit Margin

Percentage of revenue retained after accounting for all expenses

0.49%

8% 15%

Higher values indicate better overall profitability

TTM (as of 2025-04-22)

Adequate Current and Quick Ratios

1.04
Current Ratio
1.04
Quick Ratio

Both the current ratio (1.04) and quick ratio (1.04) suggest that the company has sufficient short-term assets to cover its short-term liabilities, indicating a stable liquidity position.

Free Cash Flow Per Share

1.91
Free Cash Flow Per Share

A free cash flow per share of 1.91 indicates that the company is generating positive cash flow, which is essential for operations and potential growth.

High Debt Levels

1.28
Debt to Equity Ratio
0.52
Debt to Assets Ratio

The debt-to-equity ratio of 1.28 and debt-to-assets ratio of 0.52 indicate that the company has a high level of debt relative to its equity, which could pose risks in economic downturns.

Low Interest Coverage Ratio

0.86
Interest Coverage Ratio

An interest coverage ratio of 0.86 suggests that the company may struggle to meet its interest obligations, indicating potential financial stress.

About Financial Health Metrics

Financial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.

Debt to Equity Ratio

Total debt divided by total equity

1.24x

1.0x 2.0x

Lower values indicate less financial leverage and risk

Less than 1.0 is conservative, 1.0-2.0 is moderate, >2.0 indicates high risk

Q4 2024

Current Ratio

Current assets divided by current liabilities

1.04x

1.0x 2.0x

Higher values indicate better short-term liquidity

Less than 1.0 is concerning, 1.0-2.0 is adequate, greater than 2.0 is good

Q4 2024

πŸ† Strong Financial Performance

$3.19
Normalized FFO per Share
16%
Shop Same-Store Cash NOI Growth

Ventas delivered a normalized FFO per share of $3.19 for the full year, exceeding guidance. Shop same-store cash NOI grew nearly 16%, marking the third consecutive year of double-digit growth.

πŸ“ˆ Competitive Positioning in Senior Housing

8%
Total Company Same-Store Cash NOI Growth
43%
Senior Housing NOI Share

The company benefits from compelling secular demand in senior housing and minimal supply. With nearly 8% total company same-store cash NOI growth and significant investments in senior housing, Ventas is poised for continued success.

πŸ” Data-Driven Investment Strategy

$1.9 billion
Investment Activity in 2024
$5 billion
Assets Under Management

Ventas employs a rigorous data-driven approach to identify investment opportunities, ensuring that investments are made in high-performing assets with strong projected net absorption.

No weaknesses identified.

πŸš€ Favorable Demographics for Growth

28%
Projected Growth in Over-80 Population

The upcoming surge in the senior population (over-80 demographic projected to grow by 28%) presents Ventas with a unique opportunity for growth in senior housing, especially given the current low construction starts.

πŸ—οΈ Strategic Expansion Plans

8%
Projected Increase in Shop Portfolio

Ventas plans to convert 45 large-scale senior housing communities, significantly increasing their shop footprint and enhancing NOI through targeted operator partnerships.

πŸ’‘ Investment Pipeline

$1 billion
2025 Investment Guidance

The company anticipates $1 billion in senior housing investments for 2025, with a clear line of sight on advanced stages of acquisition, underpinning their growth strategy.

No risks identified.
Home Screener Search Profile

During the beta period, we're currently displaying stocks from the S&P 500 index only. More stocks will be added soon.

Loading...